Mednax Inc (MD)

Interest coverage

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before interest and tax (EBIT) US$ in thousands -60,598 -6,284 200,000 217,738 171,933
Interest expense US$ in thousands 40,743 42,075 39,695 68,722 110,482
Interest coverage -1.49 -0.15 5.04 3.17 1.56

December 31, 2024 calculation

Interest coverage = EBIT ÷ Interest expense
= $-60,598K ÷ $40,743K
= -1.49

Interest coverage is a financial ratio that measures a company's ability to cover its interest expenses with its operating income. In the case of Mednax Inc, the interest coverage ratio has varied over the years.

As of December 31, 2020, Mednax Inc had an interest coverage ratio of 1.56, indicating that the company was generating just enough operating income to cover its interest expenses.

By December 31, 2021, the interest coverage ratio improved significantly to 3.17, suggesting that Mednax Inc's operating income had increased relative to its interest expenses, signaling a stronger financial position.

The trend continued positively as of December 31, 2022, with an interest coverage ratio of 5.04, demonstrating a healthy ability to cover interest costs with operating income.

However, the interest coverage ratio declined dramatically by December 31, 2023, dropping to -0.15, which implies that Mednax Inc's operating income was insufficient to cover its interest expenses. This may raise concerns about the company's financial health and ability to meet its debt obligations.

The situation worsened by December 31, 2024, with an interest coverage ratio of -1.49, further underscoring the challenges Mednax Inc was facing in meeting its interest payments.

Overall, fluctuations in Mednax Inc's interest coverage ratio indicate varying degrees of financial stability and solvency over the years, with a sharp decline in recent years raising red flags regarding the company's ability to manage its debt effectively.


Peer comparison

Dec 31, 2024

Company name
Symbol
Interest coverage
Mednax Inc
MD
-1.49
Encompass Health Corp
EHC
6.46
Select Medical Holdings
SEM
2.36